Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT01699737

Public ClinicalTrials.gov record NCT01699737. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of JTT-851 in Patients With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effect of JTT-851 on diabetes as well as to assess the safety, tolerability, and pharmacokinetics of JTT-851 in type 2 diabetic patients either treated with metformin or treatment-naïve.

Study identification

NCT ID
NCT01699737
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Akros Pharma Inc.
Industry
Enrollment
325 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2012 (Type not available)
Primary completion
May 2013 (Actual)
Completion
Jul 2013 (Actual)
Last update posted
Aug 1, 2013

2012 – 2013

United States locations

U.S. sites
79
U.S. states
27
U.S. cities
79
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Dothan Alabama — —
Not listed Huntsville Alabama — —
Not listed Montgomery Alabama — —
Not listed Muscle Shoals Alabama — —
Not listed Glendale Arizona — —
Not listed Tucson Arizona — —
Not listed Little Rock Arkansas — —
Not listed Artesia California — —
Not listed Beverly Hills California — —
Not listed Buena Park California — —
Not listed Chino California — —
Not listed Garden Grove California — —
Not listed Lincoln California — —
Not listed Lomita California — —
Not listed Los Angeles California — —
Not listed Newport Beach California — —
Not listed North Hollywood California — —
Not listed Paramount California — —
Not listed Sacramento California — —
Not listed Spring Valley California — —
Not listed Walnut Creek California — —
Not listed Denver Colorado — —
Not listed Cooper City Florida — —
Not listed Fort Lauderdale Florida — —
Not listed Hialeah Florida — —
Not listed Kissimee Florida — —
Not listed Miami Florida — —
Not listed Miramar Florida — —
Not listed Ocala Florida — —
Not listed Orlando Florida — —
Not listed Ormond Beach Florida — —
Not listed Pembroke Pines Florida — —
Not listed Port Orange Florida — —
Not listed Tampa Florida — —
Not listed Columbus Georgia — —
Not listed Marietta Georgia — —
Not listed Nampa Idaho — —
Not listed Chicago Illinois — —
Not listed Evanston Illinois — —
Not listed Indianapolis Indiana — —
Not listed Wichita Kansas — —
Not listed Lake Charles Louisiana — —
Not listed New Orleans Louisiana — —
Not listed Oxon Hill Maryland — —
Not listed Olive Branch Mississippi — —
Not listed Las Vegas Nevada — —
Not listed Berlin New Jersey — —
Not listed Mine Hill New Jersey — —
Not listed Glen Falls New York — —
Not listed Greensboro North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Kettering Ohio — —
Not listed Marion Ohio — —
Not listed Munroe Falls Ohio — —
Not listed Wadsworth Ohio — —
Not listed Norman Oklahoma — —
Not listed Oklahoma City Oklahoma — —
Not listed Eugene Oregon — —
Not listed Portland Oregon — —
Not listed Lansdale Pennsylvania — —
Not listed Columbia South Carolina — —
Not listed Greer South Carolina — —
Not listed Carrollton Texas — —
Not listed Corpus Christi Texas — —
Not listed Dallas Texas — —
Not listed Houston Texas — —
Not listed Plano Texas — —
Not listed San Antonio Texas — —
Not listed Sugarland Texas — —
Not listed Tomball Texas — —
Not listed Murray Utah — —
Not listed Orem Utah — —
Not listed Salt Lake City Utah — —
Not listed Burke Virginia — —
Not listed Manassas Virginia — —
Not listed Norfolk Virginia — —
Not listed Suffolk Virginia — —
Not listed Madison Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01699737, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 1, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01699737 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →